open access

Vol 4, No 1 (2003): Practical Diabetology
Original articles (translated)
Published online: 2003-02-13
Get Citation

Combination of insulin and metformin in the treatment of type 2 diabetes

Michiel G. Wulffelé, Adriaan Kooy, Philippe Lehert, Daniel Bets, Jeles C. Ogterop, Bob Borger van der Burg, Ab J.M. Donker, Coen D.A. Stehouwer
Diabetologia Praktyczna 2003;4(1):65-74.

open access

Vol 4, No 1 (2003): Practical Diabetology
Original articles (translated)
Published online: 2003-02-13

Abstract

INTRODUCTION. To investigate the metabolic effects of metformin, as compared with placebo, in type 2 diabetic patients intensively treated with insulin.
MATERIAL AND METHODS. Metformin improves glycemic control in poorly controlled type 2 diabetic patients. Its effect in type 2 diabetic patients who are intensively treated with insulin has not been studied. A total of 390 patients whose type 2 diabetes was controlled with insulin therapy completed a randomized controlled double-blind trial with a planned interim analysis after 16 weeks of treatment.The subjects were selected from three outpatient clinics in regional hospitals and were randomly assigned to either the placebo or metformin group, in addition to insulin therapy. Intensive glucose monitoring with immediate insulin adjustments according to strict guidelines was conducted. Indexes of glycemic control, insulin requirements, body weight, blood pressure, plasma lipids, hypoglycemic events, and other adverse events were measured.
RESULTS. Of the 390 subjects, 37 dropped out (12 in the placebo and 25 in the metformin group). Of those who completed 16 weeks of treatment, metformin use, as compared with placebo, was associated with improved glycemic control (mean daily glucose at 16 weeks 7.8 vs. 8.8 mmol/l, P = 0.006; mean GHb 6.9 vs. 7.6%, P < 0.0001); reduced insulin requirements (63.8 vs. 71.3 IU, P < 0.0001); reduced weight gain (–0.4 vs. +1.2 kg, P < 0.01); and decreased plasma LDL cholesterol (–0.21 vs. –0.02 mmol/l, P < 0.01). Risk of hypoglycemia was similar in both groups.
CONCLUSIONS. In type 2 diabetic patients who are intensively treated with insulin, the combination of insulin and metformin results in superior glycemic control compared with insulin therapy alone, while insulin requirements and weight gain are less.

Abstract

INTRODUCTION. To investigate the metabolic effects of metformin, as compared with placebo, in type 2 diabetic patients intensively treated with insulin.
MATERIAL AND METHODS. Metformin improves glycemic control in poorly controlled type 2 diabetic patients. Its effect in type 2 diabetic patients who are intensively treated with insulin has not been studied. A total of 390 patients whose type 2 diabetes was controlled with insulin therapy completed a randomized controlled double-blind trial with a planned interim analysis after 16 weeks of treatment.The subjects were selected from three outpatient clinics in regional hospitals and were randomly assigned to either the placebo or metformin group, in addition to insulin therapy. Intensive glucose monitoring with immediate insulin adjustments according to strict guidelines was conducted. Indexes of glycemic control, insulin requirements, body weight, blood pressure, plasma lipids, hypoglycemic events, and other adverse events were measured.
RESULTS. Of the 390 subjects, 37 dropped out (12 in the placebo and 25 in the metformin group). Of those who completed 16 weeks of treatment, metformin use, as compared with placebo, was associated with improved glycemic control (mean daily glucose at 16 weeks 7.8 vs. 8.8 mmol/l, P = 0.006; mean GHb 6.9 vs. 7.6%, P < 0.0001); reduced insulin requirements (63.8 vs. 71.3 IU, P < 0.0001); reduced weight gain (–0.4 vs. +1.2 kg, P < 0.01); and decreased plasma LDL cholesterol (–0.21 vs. –0.02 mmol/l, P < 0.01). Risk of hypoglycemia was similar in both groups.
CONCLUSIONS. In type 2 diabetic patients who are intensively treated with insulin, the combination of insulin and metformin results in superior glycemic control compared with insulin therapy alone, while insulin requirements and weight gain are less.
Get Citation

Keywords

intensive insulin treatment; metformin; diabetes mellitus type 2; combination therapy in type 2 diabetes mellitus

About this article
Title

Combination of insulin and metformin in the treatment of type 2 diabetes

Journal

Clinical Diabetology

Issue

Vol 4, No 1 (2003): Practical Diabetology

Pages

65-74

Published online

2003-02-13

Bibliographic record

Diabetologia Praktyczna 2003;4(1):65-74.

Keywords

intensive insulin treatment
metformin
diabetes mellitus type 2
combination therapy in type 2 diabetes mellitus

Authors

Michiel G. Wulffelé
Adriaan Kooy
Philippe Lehert
Daniel Bets
Jeles C. Ogterop
Bob Borger van der Burg
Ab J.M. Donker
Coen D.A. Stehouwer

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Diabetologia Kliniczna dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl